BY OUR PLATFORMS
BY THERAPEUTIC AREA
BY RESEARCH STAGE
01 January 2017 - 31 December 2017
Start – End dates: 01/01/17-31/12/17
Project reference: Neotec 2016 (SNEO-20161362)
Total budget: 609,144€
Funding agency: CDTI, Spain
The project consists of the beginning of the drug discovery phase and the ZeGlobalTox and ZeOncoTest / STEM-ZeOncoTest projects that aim to develop technologies for the characterization of toxicity and efficacy parameters of molecules in order to find out their therapeutic potential will be complete. Thus, the objective of the project is to analyze libraries of molecules provided by collaborating entities (CSIC, Pivot Park Center, LEITAT) with a view to discovering molecules with:
The expected results are to protect those molecules and nanobodies with therapeutic effects of interest with a view to their subsequent licensing to companies in the pharmaceutical sector for the development of new drugs.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.